Status:
RECRUITING
9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease
Lead Sponsor:
University Hospital, Ghent
Conditions:
Urethral Stricture
Eligibility:
All Genders
6-100 years
Brief Summary
It has been demonstrated that urethroplasty should be considered the gold standard treatment for urethral stricture disease as it yields higher long-term success rates than endoscopic treatment option...
Eligibility Criteria
Inclusion
- Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations.
- Patient age ≥ 6 years.
- If a patient reaches the age of 18 years, he or she will have to provide a new voluntarily signed written informed consent. All patients reaching the age of 18 years will be contacted by the Principal Investigator or Subinvestigator to provide a new voluntarily signed written informed consent.
Exclusion
- \- Absence of signed written informed consent and thus a patient unwilling to participate.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04071925
Start Date
September 1 2019
End Date
December 31 2029
Last Update
January 3 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Urology, Ghent University Hospital
Ghent, Belgium, 9000
2
University Hospital Ghent
Ghent, Belgium, 9000